Anti-fibrotic effect of tocotrienols for bladder dysfunction due to partial bladder outlet obstruction.

Published in: Investigative and clinical urology (2023)

Oral tocotrienol treatment reduced the progression of urinary frequency and bladder fibrosis by suppressing HIF pathways triggered by PBOO.

Keyphrases